Skip to content
Take logo

Take

TAKE NSE
₹10.54 0.40 (3.94%)
Market Cap
₹156 Cr
P/E
12.11

Take (TAKE) share price was ₹10.54 at the 28 Oct 2026 close; market capitalisation ₹156 Cr; P/E (TTM) 12.11; sector Healthcare. The share price fell 53.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹30.37 Cr, against under ₹0.01 Cr a year earlier and net profit was ₹1.06 Cr, against −₹0.91 Cr a year earlier (compared with Jun 2025). Promoters held 0.00% of Take in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 40/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹10.54 −11.96 −53.16% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹156 Cr
P/E (TTM)
12.11
EBITDA
₹4.80 Cr
Return on Equity
13.73%
Debt to Equity
0
Book Value
₹2.10
EPS (TTM)
₹0.87
52W High
₹50.14
52W Low
₹9.88

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Technology › Healthcare Research, Analytics & Technology

Syngene International
₹410.8574.8416,585 Cr3.430.34%6.54%8.35%3,613 Cr221 Cr
Indegene
₹598.9535.9514,433 Cr4.600.38%12.78%15.40%3,892 Cr401 Cr
Suven Life Sciences
₹268.05—7,574 Cr11.060.00%-46.73%-45.62%30 Cr-353 Cr
Vimta Labs
₹513.4028.762,295 Cr5.020.39%12.83%16.36%336 Cr80 Cr
Fabtech Technologies
₹125.129.40556 Cr1.330.47%9.14%11.73%441 Cr49 Cr
Take (this company)
₹10.5412.11156 Cr5.020.00%13.73%15.37%100 Cr13 Cr
Median 6 companies₹339.4528.764,934 Cr4.810.36%10.96%13.55%389 Cr64 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
40 Weak
Overall score
Data confidence 89/100

Category scores

Quality Poor 32
Returns, margins, earnings quality 24%
Valuation Weak 43
Cheap vs sector & own history 26%
Financial Health Strong 90
Solvency, leverage, coverage 10%
Momentum Poor 3
Trend strength, vol-adjusted 13%
Ownership Average 50
FII/DII/promoter flows 26%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

7
  • Stock is trading at 5.47 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -41.2% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of -47.0% over last 3 years.
  • Earnings include an other income of Rs.14.9 Cr.
  • Working capital days have increased from -2,718 days to 123 days

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
4
Bullish
3

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
497% higher than 3Y

change over 1 year

Net Income Growth
514% higher than 3Y

change over 1 year

Cash Flow Change
74.77%

change over 1 year

EBITDA Margin Change
-70.8%

change over 1 year Operating margin -0.89% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.55
0.05
0
0
0
0
0
0
0
0
0
54.19
30.37
Expenses
5.5
1.5
1.98
15.76
2.22
0.9
2.89
1.15
0.44
0.3
0.35
55.01
30.64
Operating Profit
-1.95
-1.45
-1.98
-15.76
-2.22
-0.9
-2.89
-1.15
-0.44
-0.3
-0.35
-0.82
-0.27
OPM %
-54.93%
-2900%
—
—
—
—
—
—
—
—
—
-1.51%
-0.89%
Other Income
-2.25
0.41
4.07
-93.7
-0.97
-0.23
51.31
-3.48
-0.29
6.92
1.46
5.18
1.33
Interest
0.64
0.56
0.54
0.54
0.49
0.5
0.73
0.24
0.18
0.17
0
0
0
Depreciation
0.3
0.3
0.11
0.01
0.01
0.01
0.01
0.01
0
0
0
0
0
PBT
-5.14
-1.9
1.44
-110
-3.69
-1.64
47.68
-4.88
-0.91
6.45
1.11
4.36
1.06
Tax %
3.5%
-18.42%
248.61%
0.55%
1.63%
-3.66%
0%
0%
0%
2.48%
0%
0%
0%
Net Profit
-5.32
-1.55
-2.14
-111
-3.75
-1.58
47.68
-4.88
-0.91
6.29
1.11
4.36
1.06
EPS (₹)
-0.36
-0.1
-0.14
-7.48
-0.25
-0.11
3.22
-0.33
-0.06
0.43
0.08
0.29
0.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
730
1,030
1,345
1,587
2,039
2,213
774
655
189
4
0
54
85
Expenses
581
817
1,082
1,281
1,655
2,044
847
648
208
24
7
56
86
Operating Profit
149
213
262
307
384
169
-73
7
-19
-20
-7
-2
-2
OPM %
20%
21%
20%
19%
19%
8%
-9%
1.1%
-10%
-569%
—
-3.5%
-2.1%
Other Income
8
21
13
6
11
26
-211
-677
-56
-92
47
13
15
Interest
13
15
23
21
25
41
37
29
7
2
2
0
0
Depreciation
60
74
87
104
154
167
115
80
17
1
0
0
0
PBT
85
145
165
188
216
-13
-437
-779
-99
-116
37
11
13
Tax %
6%
14%
11%
15%
17%
-15%
3%
0%
2%
3%
0%
1%
—
Net Profit
80
125
146
160
178
-11
-450
-782
-100
-120
37
11
13
EPS (₹)
5.71
9.78
10.74
10.85
11.99
-0.84
-30.56
-52.88
-6.78
-8.09
2.53
0.73
0.87
Div. Payout %
17%
10%
9%
15%
8%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12
12
13
15
15
15
15
15
15
15
15
15
Reserves
512
619
898
1,314
1,504
1,561
1,110
166
94
-24
6
16
Borrowings
209
336
237
323
474
553
514
59
46
37
0
0
Other Liabilities
189
246
221
189
339
336
187
984
69
60
16
5
Total Liabilities
922
1,214
1,369
1,840
2,331
2,465
1,826
1,223
224
88
36
36
Fixed Assets
359
543
554
589
1,091
1,234
934
101
73
30
0
0
CWIP
17
3
21
42
41
1
0
3
11
0
0
0
Investments
6
21
10
59
10
18
7
0
0
0
0
0
Other Assets
541
647
785
1,150
1,188
1,213
885
1,119
140
58
36
36
Total Assets
922
1,214
1,369
1,840
2,331
2,465
1,826
1,223
224
88
36
36
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
74
151
56
121
104
211
135
30
20
9
-16
-4
Investing
-14
-292
-130
-179
-474
-233
-57
15
-3
-7
22
2
Financing
-11
111
56
302
100
21
-84
-55
-36
-12
-3
-1
Net Cash Flow
49
-30
-18
243
-270
-2
-6
-10
-18
-10
3
-3
Free Cash Flow
46
35
-30
39
-23
54
133
-2
-12
2
-16
-4
CFO/EBITDA
52
76
26
44
30
156
-212
704
-114
-43
217
208
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
120
107
118
108
94
116
205
45
58
715
—
1
Inventory Days
—
—
—
—
—
—
—
—
—
—
—
0
Cash Conversion Cycle
120
107
118
108
94
116
205
45
58
715
—
1
Working Capital Days
42
19
90
85
67
80
140
28
-42
-5,559
—
123
ROCE %
13%
16%
17%
15%
13%
1%
-9%
-6%
-14%
-22%
11%
19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Take insights

65 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

Others68.73%FIIs0.21%Public31.05%As ofSep 2026

Documents

Frequently Asked Questions about Take

What does Take Ltd do?
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]
Where is Take Ltd (TAKE) listed?
Take Ltd trades as TAKE on the NSE and under code 532890 on the BSE.
Which sector does Take Ltd belong to?
Take Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the market capitalisation of Take Ltd?
Take Ltd has a market capitalisation of ₹155.92 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Take Ltd?
Take Ltd trades at a PE ratio of 12.11 as of 28 Oct 2026, on earnings per share of ₹0.87, against a book value of ₹2.1 per share.
What is the 52-week high and low of Take Ltd?
Over the last 52 weeks Take Ltd has traded between ₹9.88 and ₹50.14 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Take Ltd?
Take Ltd reported a return on equity of 13.73%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Website takesolutions.com
CEO Ms. Sonia Bhimrajka
Employees 2
Listed 2007-08-27
Face Value ₹ 1
Shares Outstanding 14,79,34,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TAKE.md for Take Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month